WO2006035280A8 - Antagonistes des recepteurs muscariniques - Google Patents

Antagonistes des recepteurs muscariniques

Info

Publication number
WO2006035280A8
WO2006035280A8 PCT/IB2005/002831 IB2005002831W WO2006035280A8 WO 2006035280 A8 WO2006035280 A8 WO 2006035280A8 IB 2005002831 W IB2005002831 W IB 2005002831W WO 2006035280 A8 WO2006035280 A8 WO 2006035280A8
Authority
WO
WIPO (PCT)
Prior art keywords
urinary
respiratory
treatment
receptor antagonists
formula
Prior art date
Application number
PCT/IB2005/002831
Other languages
English (en)
Other versions
WO2006035280A1 (fr
Inventor
Mohammad Salman
Anita Mehta
Naresh Kumar
Kirandeep Kaur
Arundutt Viswanatham Silamkoti
Bruhaspathy Miriyala
Shelley Aeron
Anita Chugh
Original Assignee
Ranbaxy Lab Ltd
Mohammad Salman
Anita Mehta
Naresh Kumar
Kirandeep Kaur
Arundutt Viswanatham Silamkoti
Bruhaspathy Miriyala
Shelley Aeron
Anita Chugh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Mohammad Salman, Anita Mehta, Naresh Kumar, Kirandeep Kaur, Arundutt Viswanatham Silamkoti, Bruhaspathy Miriyala, Shelley Aeron, Anita Chugh filed Critical Ranbaxy Lab Ltd
Publication of WO2006035280A1 publication Critical patent/WO2006035280A1/fr
Publication of WO2006035280A8 publication Critical patent/WO2006035280A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/24—Camphidines

Abstract

La présente invention concerne, de manière générale, des antagonistes des récepteurs muscariniques de formule (I), lesquels sont utiles, entre autres, pour le traitement de diverses maladies des systèmes respiratoire, urinaire et gastro-intestinal médiées par des récepteurs muscariniques. L'invention concerne également le procédé de préparation des composés selon l'invention, des compositions pharmaceutiques contenant lesdits composés, ainsi que les méthodes de traitement de maladies médiées par des récepteurs muscariniques. Dans la formule (I), On représente un cycle contenant de l'azote présentant entre 5 et 9 atomes de carbone et T représente un groupe de pontage sélectionné dans le groupe comprenant (CH2)n-, -CH(Q)CH2-, -CH2CH(Q)CH2-, -CH2-O-CH2- ou -CH2-NH-CH2-), n est un entier sélectionné compris entre 0 et 3 (lorsque n est égal à zéro, alors T représente une liaison directe) ; Y représente alkylène, alcénylène, alkynylène ou aucun atome ; X représente NH ou oxygène.
PCT/IB2005/002831 2004-09-27 2005-09-26 Antagonistes des recepteurs muscariniques WO2006035280A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1846/DEL/2004 2004-09-27
IN1846DE2004 2004-09-27

Publications (2)

Publication Number Publication Date
WO2006035280A1 WO2006035280A1 (fr) 2006-04-06
WO2006035280A8 true WO2006035280A8 (fr) 2006-06-08

Family

ID=35589277

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/002831 WO2006035280A1 (fr) 2004-09-27 2005-09-26 Antagonistes des recepteurs muscariniques

Country Status (1)

Country Link
WO (1) WO2006035280A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7352294B2 (ja) 2018-02-02 2023-09-28 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476297B2 (en) 2007-12-04 2013-07-02 Amgen Inc. TRP-M8 receptor ligands and their use in treatments
EP2420237A1 (fr) 2010-08-11 2012-02-22 Ville Takio Dérivés fluorés d'isoquinoléines endogènes pour leur utilisation dans le traitement de maladies liées aux passages d'isoquinoline endogène
EP3697759A4 (fr) 2017-10-20 2021-05-12 Vanderbilt University Antagonistes du récepteur muscarinique de l'acétylcholine m4
US11352344B2 (en) 2017-10-31 2022-06-07 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
US20220251084A1 (en) * 2019-06-12 2022-08-11 Arkuda Therapeutics Progranulin modulators and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258250A (ja) * 1994-03-25 1995-10-09 Yamanouchi Pharmaceut Co Ltd エステル誘導体
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
EP1534675B1 (fr) * 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Derives d'azabicyclo(3.1.0)hexanes 3,6-disubstitues contenant fluoro et sulfonylamino, utilises comme antagonistes des recepteurs de muscarine
US20040138253A1 (en) * 2002-10-29 2004-07-15 Slatter John Gregory Quaternary ammonium compounds
DE60225195T2 (de) * 2002-12-23 2009-02-26 Ranbaxy Laboratories, Ltd. Flavaxat-derivate als muscarin-rezeptor antagonisten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7352294B2 (ja) 2018-02-02 2023-09-28 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト

Also Published As

Publication number Publication date
WO2006035280A1 (fr) 2006-04-06

Similar Documents

Publication Publication Date Title
ZA200500951B (en) Azabicyclo derivatives as muscarinic receptor antagonists
DE60231341D1 (de) Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
WO2004089366A8 (fr) Composes bicycliques comme antagonistes du recepteur nr2b
CA2536870A1 (fr) Composes de phenyle ou de pyridyle amide utiles comme antagonistes de la prostaglandine e2
UA98098C2 (ru) ПРОИЗВОДНЫЕ ПИРИДИНОНА И ИХ ПРИМЕНЕНИЕ КАК ПОЛОЖИТЕЛЬНЫХ АЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ РЕЦЕПТОРОВ mGluR2
WO2006035280A8 (fr) Antagonistes des recepteurs muscariniques
DK1765816T3 (da) Substituerede 1-propinylpiperaziner med affinitet for MGluR5-receptoren til behandling af smertetilstande
HK1079787A1 (zh) 用作毒蕈碱受體拮抗劑的3，6-二取代的氮雜雙環[3．1．0]己烷衍生物
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
WO2006035282A3 (fr) Antagonistes des recepteurs muscariniques
TW200624432A (en) Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto
TW200716547A (en) Piperidin-4-yl-amide derivatives
MXPA02011418A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas del receptor muscarinico.
WO2006054162A8 (fr) Antagonistes azabicycliques des recepteurs muscariniques
EA200501593A1 (ru) Азабициклические производные в качестве антагонистов мускаринового рецептора
WO2006018708A3 (fr) Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques
ATE386738T1 (de) Flavaxat-derivate als muscarin-rezeptor antagonisten
WO2004067510A8 (fr) Derives de 3,6-disubstitues azabicyclo hexane utilises en tant qu'antagonistes du recepteur de muscarinique
AU2003214535A8 (en) Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2004080411A3 (fr) Antagonistes du recepteur de l'hormone concentrant la melanine et compositions et methodes associees
WO2007077510A3 (fr) Antagonistes des récepteurs muscariniques
WO2006032994A3 (fr) Antagonistes des recepteurs muscariniques
WO2007007281A3 (fr) Antagonistes des recepteurs muscariniques
DE602004018844D1 (de) Als antagonisten des muscarinrezeptors geeignete xanthinderivate
WO2007090836A3 (fr) Dérivés de pipéridine comme antagonistes du récepteur cxcr3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase